216 related articles for article (PubMed ID: 19705154)
1. The substantia nigra pars compacta of the Göttingen minipig: an anatomical and stereological study.
Nielsen MS; Sørensen JC; Bjarkam CR
Brain Struct Funct; 2009 Sep; 213(4-5):481-8. PubMed ID: 19705154
[TBL] [Abstract][Full Text] [Related]
2. The anatomy of the porcine subthalamic nucleus evaluated with immunohistochemistry and design-based stereology.
Larsen M; Bjarkam CR; Østergaard K; West MJ; Sørensen JC
Anat Embryol (Berl); 2004 Jun; 208(3):239-47. PubMed ID: 15168115
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine hydroxylase and acetylcholinesterase in the domestic pig mesencephalon: an immunocytochemical and histochemical study.
Ostergaard K; Holm IE; Zimmer J
J Comp Neurol; 1992 Aug; 322(2):149-66. PubMed ID: 1355778
[TBL] [Abstract][Full Text] [Related]
4. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
[TBL] [Abstract][Full Text] [Related]
5. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism.
Tatton WG; Greenwood CE
J Neurosci Res; 1991 Dec; 30(4):666-72. PubMed ID: 1686284
[TBL] [Abstract][Full Text] [Related]
6. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia Nigra.
Haber SN; Groenewegen HJ
J Comp Neurol; 1989 Dec; 290(1):53-68. PubMed ID: 2480370
[TBL] [Abstract][Full Text] [Related]
7. Continuous MPTP intoxication in the Göttingen minipig results in chronic parkinsonian deficits.
Nielsen MS; Glud AN; Møller A; Mogensen P; Bender D; Sørensen JC; Doudet D; Bjarkam CR
Acta Neurobiol Exp (Wars); 2016; 76(3):199-211. PubMed ID: 27685773
[TBL] [Abstract][Full Text] [Related]
8. A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area.
Xavier LL; Viola GG; Ferraz AC; Da Cunha C; Deonizio JM; Netto CA; Achaval M
Brain Res Brain Res Protoc; 2005 Dec; 16(1-3):58-64. PubMed ID: 16310404
[TBL] [Abstract][Full Text] [Related]
9. Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons.
Aumann TD; Egan K; Lim J; Boon WC; Bye CR; Chua HK; Baban N; Parish CL; Bobrovskaya L; Dickson P; Horne MK
J Neurochem; 2011 Feb; 116(4):646-58. PubMed ID: 21166807
[TBL] [Abstract][Full Text] [Related]
10. Does melatonin help save dopaminergic cells in MPTP-treated mice?
Ma J; Shaw VE; Mitrofanis J
Parkinsonism Relat Disord; 2009 May; 15(4):307-14. PubMed ID: 18793863
[TBL] [Abstract][Full Text] [Related]
11. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.
Garrido-Gil P; Belzunegui S; San Sebastián W; Izal-Azcárate A; López B; Marcilla I; Luquin MR
J Neurosci Res; 2009 Feb; 87(2):586-97. PubMed ID: 18798285
[TBL] [Abstract][Full Text] [Related]
12. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
Gale SD; Perkel DJ
J Neurophysiol; 2006 Nov; 96(5):2295-306. PubMed ID: 16870835
[TBL] [Abstract][Full Text] [Related]
13. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
Bian GL; Wei LC; Shi M; Wang YQ; Cao R; Chen LW
Brain Res; 2007 May; 1150():55-61. PubMed ID: 17397812
[TBL] [Abstract][Full Text] [Related]
14. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
[TBL] [Abstract][Full Text] [Related]
15. Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.
Winter C; von Rumohr A; Mundt A; Petrus D; Klein J; Lee T; Morgenstern R; Kupsch A; Juckel G
Behav Brain Res; 2007 Dec; 184(2):133-41. PubMed ID: 17698212
[TBL] [Abstract][Full Text] [Related]
16. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.
Knyihár-Csillik E; Chadaide Z; Mihály A; Krisztin-Péva B; Fenyo R; Vécsei L
Acta Neuropathol; 2006 Aug; 112(2):127-37. PubMed ID: 16788821
[TBL] [Abstract][Full Text] [Related]
17. Human GABA A receptors on dopaminergic neurons in the pars compacta of the substantia nigra.
Petri S; Krampfl K; Dengler R; Bufler J; Weindl A; Arzberger T
J Comp Neurol; 2002 Oct; 452(4):360-6. PubMed ID: 12355418
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evidence for localization of NMDAR1 receptor subunit on dopaminergic neurons of the rat substantia nigra, pars compacta.
Wedzony K; Czepiel K; Fijał K
Pol J Pharmacol; 2001; 53(6):675-9. PubMed ID: 11985345
[TBL] [Abstract][Full Text] [Related]
19. Possibility for neurogenesis in substantia nigra of parkinsonian brain.
Yoshimi K; Ren YR; Seki T; Yamada M; Ooizumi H; Onodera M; Saito Y; Murayama S; Okano H; Mizuno Y; Mochizuki H
Ann Neurol; 2005 Jul; 58(1):31-40. PubMed ID: 15912513
[TBL] [Abstract][Full Text] [Related]
20. Organization of ventral tegmental area projections to the ventral tegmental area-nigral complex in the rat.
Ferreira JG; Del-Fava F; Hasue RH; Shammah-Lagnado SJ
Neuroscience; 2008 Apr; 153(1):196-213. PubMed ID: 18358616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]